Comparative effectiveness of the BNT162b2 and ChAdOx1 vaccines against Covid-19 in people over 50
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparative effectiveness of the BNT162b2 and ChAdOx1 vaccines against Covid-19 in people over 50
Authors
Keywords
-
Journal
Nature Communications
Volume 13, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-03-21
DOI
10.1038/s41467-022-29159-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Demographic risk factors for COVID-19 infection, severity, ICU admission and death: a meta-analysis of 59 studies
- (2021) Bart G Pijls et al. BMJ Open
- BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting
- (2021) Noa Dagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Theoretical framework for retrospective studies of the effectiveness of SARS-CoV-2 vaccines
- (2021) Joseph A. Lewnard et al. EPIDEMIOLOGY
- Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: an observational cohort study using the OpenSAFELY platform
- (2021) Rohini Mathur et al. LANCET
- Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study
- (2021) Eleftheria Vasileiou et al. LANCET
- Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
- (2021) Jerald Sadoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial
- (2021) Xinxue Liu et al. LANCET
- Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial
- (2021) Alberto M Borobia et al. LANCET
- Heterologous vaccine regimens against COVID-19
- (2021) Talita Duarte-Salles et al. LANCET
- Dynamic linkage of COVID-19 test results between Public Health England’s Second Generation Surveillance System and UK Biobank
- (2020) Jacob Armstrong et al. Microbial Genomics
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
- (2020) Merryn Voysey et al. LANCET
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission
- (2020) Hannah Peckham et al. Nature Communications
- The UK Biobank resource with deep phenotyping and genomic data
- (2018) Clare Bycroft et al. NATURE
- The performance of inverse probability of treatment weighting and full matching on the propensity score in the presence of model misspecification when estimating the effect of treatment on survival outcomes
- (2015) Peter C Austin et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- Methodological challenges in measuring vaccine effectiveness using population cohorts in low resource settings
- (2015) C. King et al. VACCINE
- Optimal Caliper Width for Propensity Score Matching of Three Treatment Groups: A Monte Carlo Study
- (2013) Yongji Wang et al. PLoS One
- An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies
- (2011) Peter C. Austin MULTIVARIATE BEHAVIORAL RESEARCH
- Treatment Effects in the Presence of Unmeasured Confounding: Dealing With Observations in the Tails of the Propensity Score Distribution--A Simulation Study
- (2010) T. Sturmer et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started